The Centers for Disease Control and Prevention posted its clinical considerations for flu vaccination this week, and the most consequential line in the document is not a new recommendation. It is an explanation of why there are none.
The agency states that because of legal uncertainties and inquiries, the seasonal influenza vaccination recommendations from the July 2025 immunization schedule remain in effect for the 2026-2027 season. For households, that means the rules governing who should get a flu shot, and when, are carrying over unchanged into a season that starts now.
One thing did change, and it is easy to miss in a document that announces no policy shift. The viruses inside the vaccine are new.
The Line That Sets the Tone for the Season
The CDC's interim clinical considerations for flu vaccination were posted for health care providers and public health officials and reviewed on September 1. The document is informed by Advisory Committee on Immunization Practices recommendations, FDA licensure decisions, and the agency's general best practices for immunization.
Routine annual influenza vaccination continues as described in the immunization schedule the agency keeps referencing, issued in July 2025. The document does not announce expanded eligibility, narrowed eligibility, or a new preferred product for the general population.
What the agency does not do is explain the legal uncertainties. The phrase appears in the summary at the top of the page and is not elaborated on anywhere in the document. MedicalDaily could not independently confirm which specific proceedings the agency is referring to, and readers should treat the reason as stated rather than as fully explained.
The Strains Are New Even Though the Rules Are Not
A carried-over schedule is not the same as a carried-over shot. The FDA sets the vaccine composition for the current season, and it made its recommendation in March.
All three virus components were updated compared with last season's vaccines, including a change intended to better match the influenza A H3N2 subclade K virus that spread widely during the 2025-2026 season. Anyone who reads a carried-over recommendation as a carried-over formulation has the wrong picture.
Every seasonal flu vaccine licensed in the United States is trivalent, containing components of an influenza A H1N1 virus, an influenza A H3N2 virus, and an influenza B Victoria lineage virus. The older four-component formulation is gone because the B Yamagata lineage has not been detected in global surveillance since 2020.
Three product types remain available. Inactivated vaccines include standard-dose egg-based options such as Fluarix, Flulaval, and Fluzone, the cell-based Flucelvax, the high-dose Fluzone High-Dose for adults 65 and older, and the adjuvanted Fluad, also for adults 65 and older. Flublok, the recombinant vaccine, is approved from age nine. FluMist, the live attenuated nasal spray, is approved for ages two through 49.
Timing Advice Most People Get Wrong
The agency is specific about when to go, and the guidance runs against the instinct to get it over with early. For most people who need only one dose, vaccination should ideally be offered during September or October.
Vaccination during July and August is not recommended for most groups because protection can wane over the course of the season, a concern the agency flags as particularly relevant for older adults. The one general exception is a person who has reason to think a later appointment will not be possible. Anyone already fully vaccinated for the season should not seek a booster dose, regardless of when they received it.
There are deliberate exceptions for two groups. Children aged six months through eight years who need two doses should receive the first as soon as possible, including in July or August, so the second dose can follow at least four weeks later and ideally by the end of October. Pregnant women in their third trimester during those months can also consider early vaccination, because studies have linked maternal vaccination to reduced influenza risk in infants during the first months after birth, when they are too young to be vaccinated themselves. For pregnant women in the first or second trimester, waiting until September or October is preferable.
Vaccination should continue after October for as long as flu viruses are circulating and unexpired vaccine is available, so a late shot is far better than none.
Adults Over 65 Have a Preferred Product, and Most People Do Not
There is no preferential recommendation for one flu vaccine over another for the general population. That changes at 65.
Adults aged 65 and older should preferentially receive one of three options: the high-dose inactivated vaccine, the recombinant vaccine, or the adjuvanted inactivated vaccine. If none of the three is available at the moment of the appointment, the guidance is to give whatever age-appropriate vaccine is on hand rather than delay.
There is a narrow second exception. Solid organ transplant recipients aged 18 through 64 who are on immunosuppressive regimens may receive the high-dose or adjuvanted vaccine as acceptable options, without a preference over other age-appropriate products.
The higher-risk list is broad. It includes all children aged six months through 59 months, all adults 50 and older, people with chronic lung, heart, kidney, liver, neurologic, blood, or metabolic conditions including diabetes, people who are immunocompromised for any reason, pregnant women, nursing home residents, American Indian and Alaska Native persons, and adults with a body mass index of 40 or higher. Household contacts and caregivers of people in these groups are also emphasized.
The nasal spray carries real restrictions that families should check before assuming a needle-free option is available. It is not recommended during pregnancy, for people who are immunocompromised, for children aged two through four with asthma or recent wheezing, for those on aspirin or salicylate-containing medications, or for close contacts of severely immunosuppressed people who require a protected environment.
Egg allergy is no longer a barrier of any kind. People aged six months and older with egg allergy of any severity may receive any flu vaccine appropriate for their age and health status, with no additional safety measures beyond those used for any vaccine recipient.
The practical step for most households is unchanged and cheap. Ask a primary care office or pharmacy what they have in stock, confirm coverage with the insurer before the visit given the carried-over schedule, and aim for a September or October appointment. Anyone with questions about a specific medical history should raise them with a clinician rather than self-selecting a product.
Key Questions Answered
What actually changed for this flu season? The recommendations did not change. The CDC states that guidance from the July 2025 immunization schedule remains in effect, citing legal uncertainties and inquiries. The vaccine strains themselves were updated.
When should most people get a flu shot? September or October for most people needing one dose. July and August are not recommended for most groups because protection can fade over the season.
Are flu vaccines still four-component? No. All seasonal flu vaccines licensed in the United States are trivalent, protecting against two influenza A viruses and one influenza B Victoria lineage virus.
Is there a best vaccine for older adults? For adults 65 and older, the high-dose, recombinant, or adjuvanted vaccines are preferentially recommended. If none is available, any age-appropriate vaccine should be given rather than delaying.
Can someone with an egg allergy get a flu shot? Yes. Anyone aged six months or older with egg allergy of any severity may receive any age-appropriate flu vaccine, with no extra precautions required.
Who should not get the nasal spray? It is not recommended during pregnancy, for immunocompromised people, for children two through four with asthma or recent wheezing, for those on aspirin or salicylate-containing medicines, or for close contacts of severely immunosuppressed patients requiring a protected environment.
Is it too late to vaccinate after October? No. Vaccination should continue throughout the season as long as flu viruses are circulating and unexpired vaccine is available.
